PRKAA2 and hyperthyroidism: Lopez et al. (2010) provided compelling evidence that hyperthyroidism and ICV triiodothyronine (T3) injection inactivate hypothalamic AMPK, stimulating de novo lipogenesis, and BAT activity through the SNS (Figure 2).